PDCD1 and myocarditis: Notably, during PD-1/PD-L1 therapy, the immune system may be in an over-activated state, damaging organ systems and even causing immune-related adverse events such as myocarditis, making it imperative to comprehensively monitor the immune system and prevent systemic diseases in a timely manner.